Variant Phenotype Annotation
证据URL
https://www.pharmgkb.org/variantAnnotation/1184233739
总结
TPMT intermediate metabolizer phenotype is associated with decreased risk of leukopenia when treated with azathioprine, mercaptopurine or purine analogues in people with Inflammatory Bowel Diseases as compared to TPMT poor metabolizer phenotype.